Trial intelligence / Profile preview

Pradaxa for Stroke Prevention Post-Atrial Ablation

NCT01976507Phase 4Completed

Sponsor
Vanderbilt University Medical Center
Start
Oct 2013
Primary completion
Dec 2016
Countries
1
01

Overview

A Phase 4 trial of dabigatran in stroke, thromboembolism, sponsored by Vanderbilt University Medical Center. Started Oct 2013; status: completed.

02

Drugs

dabigatran
03

Conditions

strokethromboembolism

Beyond the preview

Go deeper on NCT01976507.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01976507.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call